抗苗勒管激素与接受体外受精联合胚胎植入前遗传学检测患者胚胎倍性无关
回顾性队列研究纳入2012年3月至2020年6月在本中心首次接受体外受精联合滋养层活检及胚胎植入前非整倍体检测(PGT-A)或PGT-A联合单基因病检测(PGT-M)的患者,排除博洛尼亚标准高龄(≥40岁)及新鲜胚胎移植者。按AMH<1.1 ng/mL分层,年龄校正回归模型显示不孕队列(n=926)与非不孕队列(n=214)中AMH分类与整倍体、嵌合体及非整倍体胚胎比例均无关联。
要点
- 不孕队列与非不孕队列中,AMH分类与整倍体、嵌合体、非整倍体胚胎比例均无关联。
- 不孕队列按年龄<35岁、35-37岁、38-39岁亚组分析,AMH分类与胚胎倍性率仍无关联。
- 不孕队列按AMH四分位分层敏感性分析,上述无关联结果持续存在。
核心结论
- 在两个接受IVF联合PGT-A(不孕患者)或PGT-A联合PGT-M(非不孕患者)的大队列中,AMH与整倍体、嵌合体或非整倍体胚胎比例均无关联,提示卵巢储备的定量耗竭不能预测胚胎队列的倍性状态。
研究设计与样本
- 回顾性队列研究,学术中心,纳入2012年3月至2020年6月在本中心首次接受IVF联合滋养层活检及PGT-A或PGT-A联合PGT-M的患者。
- 排除博洛尼亚标准高龄(年龄≥40岁)及接受新鲜胚胎移植的患者;不孕队列n=926,非不孕队列n=214,按AMH<1.1 ng/mL(博洛尼亚标准)分层。
主要发现
- 年龄校正回归模型显示,不孕队列与非不孕队列中AMH分类与整倍体、嵌合体及非整倍体胚胎比例均无关联。
- 不孕队列亚组分析中,年龄<35岁、35-37岁、38-39岁患者AMH分类与胚胎倍性率均无关联。
- 不孕队列按AMH(ng/mL)四分位分层的敏感性分析中,上述无关联结果持续存在。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the association between antimüllerian hormone (AMH) and embryo ploidy rates in 2 cohorts of patients undergoing in vitro fertilization (IVF) with trophectoderm biopsy for preimplantation genetic testing for aneuploidy (PGT-A): the general population of women pursuing IVF with PGT-A (Infertile cohort) and women pursuing IVF with preimplantation genetic testing for monogenic disorders (PGT-M) owing to the risk of hereditary monogenic diseases (Non-infertile cohort). DESIGN: Retrospective cohort study. SETTING: Academic center. PATIENT(S): Patients undergoing their first cycle of IVF with trophectoderm biopsy and PGT-A or PGT-A and PGT-M in our center between March 2012 and June 2020. Patients of advanced maternal age according to the Bologna criteria (age ≥40 years) and patients who underwent fresh embryo transfers were excluded. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Proportion of euploid, mosaic, and aneuploid embryos per cycle. RESULT(S): "Infertile" (n = 926) and "Non-infertile" (n = 214) patients were stratified on the basis of AMH levels, with low-AMH defined as <1.1 ng/mL in accordance with the Bologna criteria. Age-adjusted regression models showed no relationship between AMH classification and proportion of euploid, mosaic, and aneuploid embryos in the Infertile or Non-infertile cohorts. In the Infertile cohort, no association between AMH classification and embryo ploidy rates was identified in a subgroup analysis of patients aged <35 years, 35-37 years, and 38-39 years. These findings persisted in a sensitivity analysis of infertile patients stratified into AMH (ng/mL) quartile categories. CONCLUSION(S): No association was found between AMH and the proportion of euploid, mosaic, or aneuploid embryos in 2 large cohorts of patients undergoing IVF with PGT-A (Infertile patients) or PGT-A and PGT-M (Non-infertile patients), suggesting that a quantitative depletion of ovarian reserve does not predict the ploidy status of the embryo cohort.
引用
- Stovezky YR, Romanski PA, Bortoletto P, et al. Antimüllerian hormone is not associated with embryo ploidy in patients with and without infertility undergoing in vitro fertilization with preimplantation genetic testing. Fertil Steril. 2022. PMID: 36423663. doi:10.1016/j.fertnstert.2022.11.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。